Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Cancer Drug Targets|April 9, 2016
Targeting Signaling Pathways in Chronic Lymphocytic LeukemiaAlice F Muggen, Simar P Singh, Rudi W Hendriks, et al.
Haematologica|May 18, 2019
Responsiveness of chronic lymphocytic leukemia cells to B-cell receptor stimulation is associated with low expression of regulatory molecules of the nuclear factor-κB pathwayRuud W J Meijers, Alice F Muggen, Leticia G Leon, et al.
Human Immunology|April 7, 2015
A role for KMT1c in monocyte to dendritic cell differentiation: Epigenetic regulation of monocyte differentiationRutger J Wierda, Marieke Goedhart, Marja C J A van Eggermond, et al.
Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.
Frontiers in Oncology|September 13, 2021
Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic LeukemiaP Martijn Kolijn, Alice F Muggen, Viktor Ljungström, et al.
Oncoimmunology|April 14, 2017
HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapyAnnika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
Immunity & Ageing : I & A|September 6, 2019
The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with ageAlice F Muggen, Madelon de Jong, Ingrid L M Wolvers-Tettero, et al.
Haematologica|May 21, 2016
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptorsLesley-Ann Sutton, Emma Young, Panagiotis Baliakas, et al.
The Journal of Experimental Medicine|May 20, 2015
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemiaLarry Mansouri, Lesley-Ann Sutton, Viktor Ljungström, et al.
Leukemia|September 11, 2024
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemiaDaniel Hägerstrand, Blaž Oder, Diego Cortese, et al.
Pageof 1